Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial

INTRODUCTION: This study assessed the efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in insufficiently controlled people with type 2 diabetes. RESEARCH DESIGN AND METHODS: COBALTA (for its acronym in Spanish, COntrol Basal d...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Antonio, Carrasco-Sánchez, Francisco Javier, González, Carlos, Seguí-Ripoll, José Miguel, Trescolí, Carlos, Ena, Javier, Borrell, Mireia, Gomez Huelgas, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488802/
https://www.ncbi.nlm.nih.gov/pubmed/32928792
http://dx.doi.org/10.1136/bmjdrc-2020-001518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488802/
https://www.ncbi.nlm.nih.gov/pubmed/32928792
http://dx.doi.org/10.1136/bmjdrc-2020-001518

Ejemplares similares